LBP AM SA decreased its holdings in Medtronic PLC (NYSE:MDT - Free Report) by 53.1% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 173,266 shares of the medical technology company's stock after selling 195,854 shares during the period. LBP AM SA's holdings in Medtronic were worth $15,570,000 at the end of the most recent reporting period.
Several other large investors have also recently modified their holdings of MDT. Burkett Financial Services LLC increased its stake in shares of Medtronic by 185.0% in the first quarter. Burkett Financial Services LLC now owns 285 shares of the medical technology company's stock worth $26,000 after purchasing an additional 185 shares in the last quarter. Rakuten Securities Inc. increased its stake in shares of Medtronic by 753.8% in the fourth quarter. Rakuten Securities Inc. now owns 333 shares of the medical technology company's stock worth $27,000 after purchasing an additional 294 shares in the last quarter. Wood Tarver Financial Group LLC bought a new position in shares of Medtronic in the fourth quarter valued at approximately $27,000. Columbia River Financial Group LLC bought a new position in shares of Medtronic in the first quarter valued at approximately $28,000. Finally, Optiver Holding B.V. bought a new position in shares of Medtronic in the fourth quarter valued at approximately $31,000. Hedge funds and other institutional investors own 82.06% of the company's stock.
Wall Street Analyst Weigh In
A number of equities analysts have recently commented on the stock. Citigroup raised their price objective on shares of Medtronic from $98.00 to $99.00 and gave the company a "buy" rating in a research report on Wednesday. Mizuho cut their price objective on shares of Medtronic from $100.00 to $98.00 and set an "outperform" rating for the company in a research report on Thursday, May 22nd. Leerink Partners assumed coverage on shares of Medtronic in a research report on Monday, June 16th. They issued an "outperform" rating and a $110.00 price objective for the company. Robert W. Baird cut their price objective on shares of Medtronic from $94.00 to $92.00 and set a "neutral" rating for the company in a research report on Thursday, May 22nd. Finally, Royal Bank Of Canada cut their price objective on shares of Medtronic from $105.00 to $101.00 and set an "outperform" rating for the company in a research report on Thursday, May 22nd. Nine research analysts have rated the stock with a hold rating, nine have given a buy rating and two have issued a strong buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $97.47.
View Our Latest Stock Analysis on MDT
Medtronic Trading Up 0.7%
Shares of MDT traded up $0.62 during mid-day trading on Friday, reaching $90.02. The company's stock had a trading volume of 12,258,801 shares, compared to its average volume of 7,027,364. The stock has a market cap of $115.45 billion, a PE ratio of 24.87, a P/E/G ratio of 2.33 and a beta of 0.80. The company has a current ratio of 1.85, a quick ratio of 1.42 and a debt-to-equity ratio of 0.53. Medtronic PLC has a 52 week low of $76.68 and a 52 week high of $96.25. The company's fifty day moving average price is $85.77 and its two-hundred day moving average price is $86.86.
Medtronic (NYSE:MDT - Get Free Report) last announced its quarterly earnings data on Wednesday, May 21st. The medical technology company reported $1.62 earnings per share for the quarter, topping analysts' consensus estimates of $1.58 by $0.04. The firm had revenue of $8.93 billion during the quarter, compared to analyst estimates of $8.81 billion. Medtronic had a net margin of 13.90% and a return on equity of 14.54%. The business's quarterly revenue was up 3.9% on a year-over-year basis. During the same period in the previous year, the business posted $1.46 EPS. On average, analysts predict that Medtronic PLC will post 5.46 earnings per share for the current fiscal year.
Medtronic Increases Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Friday, July 11th. Stockholders of record on Friday, June 27th were issued a $0.71 dividend. This represents a $2.84 dividend on an annualized basis and a dividend yield of 3.15%. This is a positive change from Medtronic's previous quarterly dividend of $0.70. The ex-dividend date of this dividend was Friday, June 27th. Medtronic's payout ratio is presently 78.45%.
About Medtronic
(
Free Report)
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software.
Further Reading
Before you consider Medtronic, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Medtronic wasn't on the list.
While Medtronic currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
